- Treatment & Clinical Trials
- In the News
- Current Research
- Archive: News ∙ Clinical Trials
Treatment & Clinical Trials
Phase 3 Prevention Trial showed 81% reduced risk of symptomatic SARS-COV-2 infections with subcutaneous administration of REGEN-COV™ (CASIRIVIMAB WITH IMDEVIMAB). University of Minnesota Medical School, Site Investigators: Dr. Anne-Marie Leuck, Dr. Mahsa Abassi, Dr. Matthew Pullen | View Press Release
Dr. Susan Kline, Principal Investigator, is Enrolling volunteers for Phase 3 Study of NVX-CoV2373 Vaccine. Learn More
Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. University of Minnesota is enrolling volunteers in a research study for individuals living with someone who recently tested positive for COVID-19. Learn More
Dr. David Boulware's hydroxychloroquine trial on early outpatient treatment of COVID-19 has been published in the Annals of Internal Medicine. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Dr. David Boulware discusses his Hydroxychloroquine trial on Open Forum Infectious Diseases podcast. How to Conduct a Clinical Trial During a Pandemic
In the News
Dr. Tim Schacker was interviewed by the Los Angeles Times about the global race between vaccinations and new COVID-19 variants.
Dr. Tim Schacker was interviewed by Medscape on the recommended pause in administering the J&J COVID-19 vaccine. Watch now.
Dr. Susan Kline was honored in “Health Care Heroes” by Minneapolis/St. Paul Business Journal, in the Category: Medical Researcher. This award honors a physician-scientist or research scientist working in the Twin Cities and making great strides within his or her research specialty. Read More
Dr. David Boulware was interviewed by Kaiser Health News about his involvement in a nationwide COVID-19 clinical trial of fluvoxamine. Read Story
For Better Science article "Die with a smile: antidepressants against COVID-19" quotes Dr. David Boulware, discussing Fluvoxamine. Read Story
Dr. Tyler Bold’s Lab is conducting research on antibody prevention of reinfection in his study SERUM SARS-COV-2 NEUTRALIZATION ACTIVITY. Learn More
A study led by Infectious Diseases Dr. Geoffrey Hart and Dr. Marco Pravetoni (Pharmacology): Understanding Protective Antibody Mechanisms in COVID-19 to Engineer Universal Coronavirus Vaccine. Learn More
Archive: News ∙ Clinical Trials
About our Division
- Talented Faculty
- Opportunities for Fellows
- Think & Act Globally
The Division of Infectious Diseases and International Medicine (IDIM) has more than 50 faculty overseeing programs in clinical care, education, and research at five teaching hospitals affiliated with the University of Minnesota Medical School: University of Minnesota Medical Center (UMMC), Minneapolis VA Health Care System, Hennepin County Medical Center, Regions Hospital, and Abbott Northwestern Hospital.
Each of these institutions serves somewhat different patient populations, and the clinical and research programs at these sites together with opportunities in global health, provide a remarkable breadth of expertise and academic experiences for trainees in the IDIM Division.
Research & Collaboration
In addition to our clinical scholars and physician scientists with clinical responsibilities, five full-time research faculty contribute importantly to the research mission of our division. The Center for Infectious Diseases and Microbiology Translational Research, an interdisciplinary research center, is the base of operation for these faculty members. Epidemiological research is carried out with colleagues in the School of Public Health, which helps administrate the division’s NIH-funded MPH/MSc-related training program. The Division also benefits from collaborations with faculty members who hold joint academic appointments in other departments, colleagues in the Center for Infectious Diseases Research and Policy, the College of Veterinary Medicine, the Minnesota Department of Health, and a number of community-based Infectious Diseases faculty.
Opportunities for Fellows
Opportunities for Fellows
During their research training, Infectious Diseases Fellows can enter an NIH-supported epidemiology (MPH)/clinical research (MSc) pathway coordinated by the School of Public Health, or they can select a laboratory-based research project at several training sites, including the Center for Translational Research in Microbiology and Infectious Diseases.
Think & Act Globally
Think & Act Globally
Because of a large influx of immigrants to Minnesota and increasing challenges from emerging infections here and abroad, especially in developing countries, our goal is to: "Think and act locally and globally."
About this Conference
The ID Intercity Clinical Case Conference is a regularly scheduled didactic session, sponsored by the Infectious Diseases Division in the Department of Medicine. Presenters are invited from the University of Minnesota, the Minnesota Department of Health and the ID community.
Held weekly on Tuesday mornings throughout the year (with the exception of July), case presentations are interactive and frequently presented as “unknowns,” encouraging discovery and participation with the audience in diagnosis and treatment remedies. Fellows, residents, students, faculty and members of the ID community all present and participate. This series is open to the public and sessions are streamed live and often recorded.
Dr. Jo-Anne Young is the conference director and Betsy Wehrwein is the organizer. For further information, please contact email@example.com.